Pharmaceuticals

Sumika Chemical Analysis Service, Ltd. (SCAS) offers comprehensive analytical services tailored to each stage of drug discovery, from research and development, regulatory submission, and post-marketing surveillance.
We provide advanced analytical technologies to evaluate the efficacy, safety and quality of a wide range of pharmaceutical modalities, including small-size molecules, medium-size molecules (nucleic acids and peptides), biologics (proteins and antibodies), and regenerative medicine for cell and gene therapies.
As a reliable and trustworthy partner in pharmaceutical research, development and quality control, we offer optimal solutions that support your businesses.

Leveraging our state-of-the-art analytical platforms, cutting-edge methodologies and over 50 years of accumulated expertise, SCAS proposes innovative solutions that create tangible value and generate best outcomes exceeding expectations. We are committed to supporting clients facing unprecedented challenges and exploring new therapeutic possibilities.

SCAS ensures data reliability and regulatory compliance by adhering to global standards, including GLP (Good Laboratory Practice), GMP (Good Manufacturing Practice), and other Japanese and international regulations, guidelines, and major pharmacopeias (Japanese Pharmacopoeia, USP and EP), as well as DI (data integrity) requirements.
Our extensive experience includes successful inspections by regulatory authorities such as the US FDA (Food and Drug Administration) and audits from both Japanese and global clients. We are highly regarded for our robust response capabilities during the regulatory inspections.